Concord Healthcare Group Co., Ltd. (HKG:2453)

Market Cap	891.40M -83.3%
Revenue (ttm)	405.68M -21.6%
Net Income	-479.89M
EPS	-0.67
Shares Out	627.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	267,000
Average Volume	427,190
Open	1.450
Previous Close	1.420
Day's Range	1.310 - 1.450
52-Week Range	1.280 - 8.960
Beta	-2.79
RSI	35.73
Earnings Date	Mar 27, 2026

About Concord Healthcare Group

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People’s Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company also offers oncology-related services, including sale and installation of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipm...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 573
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2453

Financial Performance

In 2024, Concord Healthcare Group's revenue was 388.31 million, a decrease of -27.91% compared to the previous year's 538.65 million. Losses were -443.22 million, 18.8% more than in 2023.

Financial numbers in CNY